Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Invested Capital (2021 - 2025)

Rapid Micro Biosystems' Return on Invested Capital history spans 5 years, with the latest figure at 0.92% for Q3 2025.

  • For Q3 2025, Return on Invested Capital fell 34.0% year-over-year to 0.92%; the TTM value through Sep 2025 reached 0.92%, down 34.0%, while the annual FY2024 figure was 0.52%, 12.0% down from the prior year.
  • Return on Invested Capital for Q3 2025 was 0.92% at Rapid Micro Biosystems, down from 0.77% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.24% in Q2 2021 and bottomed at 1.21% in Q3 2021.
  • The 5-year median for Return on Invested Capital is 0.46% (2023), against an average of 0.49%.
  • The largest YoY upside for Return on Invested Capital was 89bps in 2022 against a maximum downside of -52bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.21% in 2021, then crashed by -76bps to 0.36% in 2022, then decreased by -26bps to 0.46% in 2023, then plummeted by -36bps to 0.63% in 2024, then crashed by -47bps to 0.92% in 2025.
  • Per Business Quant, the three most recent readings for RPID's Return on Invested Capital are 0.92% (Q3 2025), 0.77% (Q2 2025), and 0.67% (Q1 2025).